Loading Events

« All Events

  • This event has passed.

Cell & Gene Therapy Symposium

September 7, 2023 @ 9:30 am - 5:00 pm

On September 7th, California Life Sciences and our member Johnson & Johnson Innovation will come together to co-host our West Coast Symposium focusing on Cell and Gene Therapy – Advancing Next Generation Therapies.

REGISTER»

Program Agenda

9:30am | Registration Opens

10:00am | Opening Remarks

Melinda Richter, Global Head, Johnson & Johnson Innovation JLABS & Mike Guerra, President and Chief Executive Officer, California Life Sciences

10:10-10:30am | Keynote Speaker

Dr. David B. Miklos, Chief, BMT & Cellular Therapy, Professor of Medicine, Stanford University

10:30-10:50am | Fireside Chat

Rich Tillyer, Global Head of Discovery, Product Development and Supply, Johnson & Johnson with Edwin (Ed) Hill, Patient Advocate

10:50-11:10am | Break & Poster Voting

11:10am-12:00pm | Panel: Investment – Funding, Opportunities, & Challenges

Sponsored by Centre for Commercialization of Regenerative Medicine, CCRM

Moderated by: Asish Xavier, Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC

Panelists: Shyam Patel, Director of Business Development, California Institute for Regenerative Medicine – CIRM; Eric Shiosaki, Partner, DCVC Bio; Nancy Hong, Managing Director, RiverVest; Cynthia Levoie, AllosteRx and Centre for Commercialization of Regenerative Medicine – CCRM

12:00-1:00pm | Luncheon & Poster Voting

1:00-1:40pm | Panel: Scientific – Next Gen CAR Design and Screening

Moderated by: Chuck Drake, VP Immuno-Oncology, Johnson & Johnson

Panelists: Andreia Costa, Director, Cell Therapy Platform Discovery, Johnson & Johnson; Justin Farlow, Chief Technology Officer, Serotiny; Aaron Foster, Chief Scientific Officer, Outpace Bio; Jordan Jarjoun, Chief Scientific Officer, Moonlight Bio

1:40-2:00pm | Break & Poster Voting

2:00-2:50pm | Panel: Advances in Manufacturing

Sponsored by OmniaBio

Moderated by: Michael May, President and Chief Executive Officer, Centre for Commercialization of Regenerative Medicine – CCRM*

Panelists: John Knighton, VP Cell & Gene Therapy, Johnson & Johnson; Ian Gaudet, Senior Director and Site Head, Miltenyi Biotec; Mazen Karaman, Director of Platform Management, Resilience; Fabian Gerlinghaus, Chief Executive Officer, Cellares; Jenifer Wheat, Chief Commercial Officer, OmniaBio*

2:50-3:00pm | Closing Remarks

Melinda Richter, Global Head, Johnson & Johnson Innovation JLABS & Mike Guerra, President and Chief Executive Officer, California Life Sciences

3:00-5:00pm | Networking Reception & Poster Viewing, sponsored by Agilent

*Invited

Program under development, speakers subject to change.

Cell & Gene Therapy QuickPitch Poster Session

Applications are now closed. Please join us on September 7th to view the pitches and vote for your favorite QuickPitch finalist!

Thank you to our esteemed panel of judges who will meet with each of the selected finalists in-person.

Thank you to our sponsors!

Sponsorship opportunities are available – demonstrate your thought leadership, broaden your network, and gain corporate visibility. Contact Emily Morgan ([email protected]) to learn more.

Other

Location
Northern California

Venue

Johnson & Johnson Innovation
1600 Sierra Point Parkway
Brisbane, CA 94005 United States
+ Google Map